Up-regulated PAR-2-mediated salivary secretion in mice deficient in muscarinic acetylcholine receptor subtypes

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 2, 2007, Pages 516-524

  Nishiyama, Tatsuaki ^a,b   Nakamura, Takeshi ^c   Obara, Kumi ^a   Inoue, Hiroko ^a   Mishima, Kenji ^a   Matsumoto, Nagisa ^d   Matsui, Minoru ^d   Manabe, Toshiya ^d   Mikoshiba, Katsuhiko ^c,d   Saito, Ichiro ^a,b  

^a TSURUMI UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; BETA GALACTOSIDASE; CALCIUM; ISOPRENALINE; MUSCARINIC RECEPTOR; PILOCARPINE; PROTEINASE ACTIVATED RECEPTOR 2; SERYLLEUCYLISOLEUCYLGLYCYLARGINYLLEUCINE HYDROXIDE; UNCLASSIFIED DRUG;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SALIVATION; SUBMANDIBULAR GLAND;

ANIMALS; CALCIUM; ISOPROTERENOL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGOPEPTIDES; PILOCARPINE; RECEPTOR, PAR-2; RECEPTORS, MUSCARINIC; SALIVA; SUBMANDIBULAR GLAND;

EID: 33846450259     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.113092     Document Type: Article

References (40)

1. Al-Ani B and Hollenberg MD (2003) Selective tryptic cleavage at the tethered ligand site of the amino terminal domain of proteinase-activated receptor-2 in intact cells. J Pharmacol Exp Ther 304:1120-1128.
2. Al-Ani B, Saifeddine M, Kawabata A, and Hollenberg MD (1999) Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation. Br J Pharmacol 128:1105-1113.
3. Bacman S, Berra A, Sterin-Borda L, and Borda E (2001) Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome. Investig Ophthalmol Vis Sci 42:321-327.
4. Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, Dorfleutner A, Carmeliet P, Mueller BM, Friedlander M, and Ruf W (2004) Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 10:502-509.
5. Bivona PL (1998) Xerostomia. A common problem among the elderly. NY State Dent J 64:46-52.
6. 2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active. J Biol Chem 271:29034-29042.
7. Corvera CU, Dery O, McConalogue K, Bohm SK, Khitin LM, Caughey GH, Payan DG, and Bunnett NW (1997) Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. J Clin Investig 100:1383-1393.
8. Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, and Smith PM (2006) Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 54:1165-1173.
9. Dery O, Corvera CU, Steinhoff M, and Bunnett NW (1998) Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 274: C1429-C1452.
10. Ekstrom J (1987) Neuropeptides and secretion. J Dent Res 66:524-530.
11. Ferrell WR, Lockhart JC, Kelso EB, Dunning L, Plevin R, Meek SE, Smith AJ, Hunter GD, McLean JS, McGarry F, et al. (2003) Essential role for proteinaseactivated receptor-2 in arthritis. J Clin Investig 111:35-41.
12. Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Nakamura K, Uchida K, Kitaguchi T, Takahashi-Iwanaga H, Noda T, Aruga J, et al. (2005) IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science (Wash DC) 309:2232-2234.
13. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
14. Hollenberg MD, Laniyonu AA, Saifeddine M, and Moore GJ (1993) Role of the aminoand carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypes. Mol Pharmacol 43:921-930.
15. Kawabata A, Kanke T, Yonezawa D, Ishiki T, Saka M, Kabeya M, Sekiguchi F, Kubo S, Kuroda R, Iwaki M, et al. (2004a) Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo. J Pharmacol Exp Ther 309:1098-1107.
16. Kawabata A, Kawao N, Itoh H, Shimada C, Takebe K, Kuroda R, Masuko T, Kataoka K, and Ogawa S (2002a) Role of N-methyl-D-aspartate receptors and the nitric oxide pathway in nociception/hyperalgesia elicited by protease-activated receptor-2 activation in mice and rats. Neurosci Lett 329:349-353.
17. Kawabata A, Kinoshita M, Nishikawa H, Kuroda R, Nishida M, Araki H, Arizono N, Oda Y, and Kakehi K (2001) The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J Clin Investig 107:1443-1450.
18. Kawabata A and Kuroda R (2000) Protease-activated receptor (PAR), a novel family of G protein-coupled seven trans-membrane domain receptors: activation mechanisms and physiological roles. Jpn J Pharmacol 82:171-174.
19. Kawabata A, Kuroda R, Nishida M, Nagata N, Sakaguchi Y, Kawao N, Nishikawa H, Arizono N, and Kawai K (2002b) Protease-activated receptor-2 (PAR-2) in the pancreas and parotid gland: immunolocalization and involvement of nitric oxide in the evoked amylase secretion. Life Sci 71:2435-2446.
20. Kawabata A, Morimoto N, Nishikawa H, Kuroda R, Oda Y, and Kakehi K (2000a) Activation of protease-activated receptor-2 (PAR-2) triggers mucin secretion in the rat sublingual gland. Biochem Biophys Res Commun 270:298-302.
21. Kawabata A, Nakaya Y, Ishiki T, Kubo S, Kuroda R, Sekiguchi F, Kawao N, Nishikawa H, and Kawai K (2004b) Receptor-activating peptides for PAR-1 and PAR-2 relax rat gastric artery via multiple mechanisms. Life Sci 75:2689-2702.
22. Kawabata A, Nishikawa H, Kuroda R, Kawai K, and Hollenberg MD (2000b) Proteinase-activated receptor-2 (PAR-2): regulation of salivary and pancreatic exocrine secretion in vivo in rats and mice. Br J Pharmacol 129:1808-1814.
23. Kawagoe J, Takizawa T, Matsumoto J, Tamiya M, Meek SE, Smith AJ, Hunter GD, Plevin R, Saito N, Kanke T, et al. (2002) Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear. Jpn J Pharmacol 88:77-84.
24. Koshikawa N, Nagashima Y, Miyagi Y, Mizushima H, Yanoma S, Yasumitsu H, and Miyazaki K (1997) Expression of trypsin in vascular endothelial cells. FEBS Lett 409:442-448.
25. Lerner DJ, Chen M, Tram T, and Coughlin SR (1996) Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function. J Biol Chem 271:13943-13947.
26. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, and Plevin R (2001) Proteinaseactivated receptors. Pharmacol Rev 53:245-282.
27. Maeda A, Kubo T, Mishina M, and Numa S (1988) Tissue distribution of mRNAs encoding muscarinic acetylcholine receptor subtypes. FEBS Lett 239:339-342.
28. Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y, Takahashi S, and Taketo MM (2000) Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA 97:9579-9584.
29. Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A, Hoxie JA, Schechter N, Woolkalis M, and Brass LF (1997) Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 272:4043-4049.
30. Mule F, Baffi MC, Falzone M, and Cerra MC (2002) Signal transduction pathways involved in the mechanical responses to protease-activated receptors in rat colon. J Pharmacol Exp Ther 303:1265-1272.
31. Nagaraju K, Cox A, Casciola-Rosen L, and Rosen A (2001) Novel fragments of the Sjogren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death. Arthritis Rheum 44:2376-2386.
32. Nakamura T, Matsui M, Uchida K, Futatsugi A, Kusakawa S, Matsumoto N, Nakamura K, Manabe T, Taketo MM, and Mikoshiba K (2004) M3 muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice. J Physiol (Lond) 558:561-575.
33. Nystedt S, Emilsson K, Wahlestedt C, and Sundelin J (1994) Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91:9208-9212.
34. Ohno-Shosaku T, Matsui M, Fukudome Y, Shosaku J, Tsubokawa H, Taketo MM, Manabe T, and Kano M (2003) Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur J Neurosci 18:109-116.
35. 2+ signaling in guinea pig tracheal epithelial cells. Life Sci 71:547-558.
36. Rose K, Allan A, Gauldie S, Stapleton G, Dobbie L, Dott K, Martin C, Wang L, Hedlund E, Seckl JR, et al. (2001) Neurosteroid hydroxylase CYP7B: vivid reporter activity in dentate gyrus of gene-targeted mice and abolition of a widespread pathway of steroid and oxysterol hydroxylation. J Biol Chem 276:23937-23944.
37. Slomiany BL, Sengupta S, Piotrowski E, Lopez RA, and Slomiany A (1992) Role of adrenergic and cholinergic mediators in salivary phospholipids secretion. Biochim Biophys Acta 1124:171-177.
38. Takuma T, Ichida T, and Kumegawa M (1985) Regulation of functional mRNA levels for trypsin-like esteroproteases by 5 alpha-dihydrotestosterone and triiodothyronine in mouse submandibular salivary gland. Arch Oral Biol 30:727-730.
39. Takuma T and Kumegawa M (1981) Postnatal development of trypsin-like esteroproteases in mouse submandibular gland. Histochemistry 72:25-31.
40. Wiseman LR and Faulds D (1995) Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs 49:143-155.